Atossa Therapeutics
ATOS
#9237
Rank
C$0.14 B
Marketcap
C$1.10
Share price
5.24%
Change (1 day)
-34.37%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2025 (TTM): -C$40.02 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -C$35.24 Million, an increase over its 2023 earnings that were of -C$41.58 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$40.02 Million13.57%
2024 -C$35.24 Million-15.25%
2023 -C$41.58 Million11.62%
2022 -C$37.25 Million30.84%
2021 -C$28.47 Million15.58%
2020 -C$24.63 Million3.41%
2019 -C$23.82 Million51.16%
2018 -C$15.76 Million40.41%
2017 -C$11.23 Million27.54%
2016 -C$8.8 Million-47.49%
2015 -C$16.76 Million-17.25%
2014 -C$20.25 Million35.91%
2013 -C$14.9 Million112.3%
2012 -C$7.02 Million46.53%
2011 -C$4.79 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$44.75 B-112,907.30%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
C$1.84 B-4,742.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
C$1.77 B-4,581.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-C$10.84 Million-72.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
C$57.58 M-245.14%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-C$0.16 Billion 280.29%๐Ÿ‡บ๐Ÿ‡ธ USA